Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119319845 | 11931984 | 5 | F | 20160809 | 20160120 | 20160817 | EXP | US-PFIZER INC-2016027679 | PFIZER | 60.00 | YR | F | Y | 82.00000 | KG | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119319845 | 11931984 | 1 | PS | LYRICA | PREGABALIN | 1 | 100 MG, 2X/DAY | Y | 21446 | 100 | MG | CAPSULE, HARD | BID | ||||||
| 119319845 | 11931984 | 2 | SS | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY | Y | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 119319845 | 11931984 | 3 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 3X/DAY | Y | 21446 | 75 | MG | CAPSULE, HARD | TID | ||||||
| 119319845 | 11931984 | 4 | SS | LYRICA | PREGABALIN | 1 | 20 MG, 3X/DAY | Y | 21446 | 20 | MG | CAPSULE, HARD | TID | ||||||
| 119319845 | 11931984 | 5 | C | TOPAMAX | TOPIRAMATE | 1 | 100 MG, 3X/DAY (AT BED TIME) | 0 | 100 | MG | TID | ||||||||
| 119319845 | 11931984 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 88 MCG ONE TABLET, DAILY | 0 | 88 | UG | TABLET | |||||||
| 119319845 | 11931984 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK, DAILY (1.5 PILL A DAY) | 0 | TABLET | ||||||||||
| 119319845 | 11931984 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 2 MG, 1X/DAY AT BEDTIME | 0 | 2 | MG | TABLET | QD | |||||||
| 119319845 | 11931984 | 9 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 2 MG, UNK | 0 | 2 | MG | TABLET | ||||||||
| 119319845 | 11931984 | 10 | C | OMEPRAZOLE DR | OMEPRAZOLE | 1 | Oral | 20 MG, 1X/DAY EVERY MORNING AFTER BREAKFAST | 0 | 20 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 119319845 | 11931984 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 60 MG (40MG ONE AND ONE HALF), 1X/DAY | 0 | 60 | MG | QD | |||||||
| 119319845 | 11931984 | 12 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 119319845 | 11931984 | 13 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 119319845 | 11931984 | 14 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 119319845 | 11931984 | 15 | C | KLOR-CON M20 | POTASSIUM CHLORIDE | 1 | 1 DF, DAILY | 0 | 1 | DF | TABLET | ||||||||
| 119319845 | 11931984 | 16 | C | LEVOTHROID | LEVOTHYROXINE SODIUM | 1 | 100 MG, DAILY | 0 | 100 | MG | TABLET | ||||||||
| 119319845 | 11931984 | 17 | C | SUCRALFATE. | SUCRALFATE | 1 | 1 G, UNK | 0 | 1 | G | |||||||||
| 119319845 | 11931984 | 18 | C | LASIX | FUROSEMIDE | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 119319845 | 11931984 | 19 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 1 MG, DAILY | 0 | 1 | MG | |||||||||
| 119319845 | 11931984 | 20 | C | CELEBREX | CELECOXIB | 1 | UNK | 0 | |||||||||||
| 119319845 | 11931984 | 21 | C | STELARA | USTEKINUMAB | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119319845 | 11931984 | 1 | Fibromyalgia |
| 119319845 | 11931984 | 2 | Rheumatoid arthritis |
| 119319845 | 11931984 | 3 | Psoriatic arthropathy |
| 119319845 | 11931984 | 4 | Arthritis |
| 119319845 | 11931984 | 5 | Migraine |
| 119319845 | 11931984 | 6 | Thyroid disorder |
| 119319845 | 11931984 | 8 | Insomnia |
| 119319845 | 11931984 | 10 | Gastric disorder |
| 119319845 | 11931984 | 11 | Joint swelling |
| 119319845 | 11931984 | 12 | Blood potassium decreased |
| 119319845 | 11931984 | 13 | Inflammation |
| 119319845 | 11931984 | 21 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119319845 | 11931984 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119319845 | 11931984 | Arthritis | |
| 119319845 | 11931984 | Condition aggravated | |
| 119319845 | 11931984 | Contusion | |
| 119319845 | 11931984 | Fall | |
| 119319845 | 11931984 | Intentional product misuse | |
| 119319845 | 11931984 | Joint swelling | |
| 119319845 | 11931984 | Musculoskeletal chest pain | |
| 119319845 | 11931984 | Pain | |
| 119319845 | 11931984 | Pain in extremity | |
| 119319845 | 11931984 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119319845 | 11931984 | 2 | 20151001 | 0 |